PROFUND ADVISORS LLC

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in IOVA

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$683,632

-$27,969 QoQ

Shares Held

194,767

-25.3% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,565,563 across 158 Biotechnology names. IOVA ranks #81 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$683,632	194,767	-25.3%	Shares	Sole	2026-04-27
2025-12-31	$711,601	260,660	+149.7%	Shares	Sole	2026-02-06
2025-09-30	$226,563	104,407	+66.1%	Shares	Sole	2025-11-06
2025-06-30	$108,098	62,848	-29.0%	Shares	Sole	2025-08-07
2025-03-31	$294,834	88,539	-17.9%	Shares	Sole	2025-05-08
2024-12-31	$798,334	107,883	-16.2%	Shares	Sole	2025-02-14
2024-09-30	$1,209,469	128,804	+3.3%	Shares	Sole	2024-11-14
2024-06-30	$999,773	124,660	+33.1%	Shares	Sole	2024-08-13
2024-03-31	$1,387,893	93,650	-53.7%	Shares	Sole	2024-05-08
2023-12-31	$1,645,723	202,426	-19.2%	Shares	Sole	2024-02-14
2023-09-30	$1,139,820	250,510	+31.1%	Shares	Sole	2023-11-13
2023-06-30	$1,345,224	191,083	-5.4%	Shares	Sole	2023-08-10
2023-03-31	$1,234,446	202,037	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.